Fig. 1 · Structure
Documents & Downloads
Alloc-DOX
Doxorubicin Prodrug
Alloc-DOX is an N-Alloc doxorubicin prodrug that selectively targets cancer cells. Upon activation by a catalyst, such as nano-palladium, Alloc-DOX demonstrates potent cytotoxic effects, resulting in reduced cell viability and tumor growth. This reagent is valuable in cancer research for studying prodrug activation mechanisms and evaluating treatment efficacy in tumor models.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 561022-65-9 |
| Applications | Doxorubicin Prodrug |
| Formula | C31H33NO13 |
| Molecular Weight | 627.59 |
| Synonyms | N-Alloc doxorubicin |
| SMILES | OC1=C(C(C2=CC=CC(OC)=C2C3=O)=O)C3=C(O)C4=C1C[C@](C(CO)=O)(O)C[C@@H]4O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)NC(OCC=C)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.